Evidence map›Paper›PMID 38204806›Full record

ArticleJournal of public health in Africa2023

Protection level of anti-hepatitis B vaccine and immunoglobulin in a pediatric Cameroonian population.

Merveille Kemenang, Rene Essomba, Aubin Nanfack, Paul Fernand Endja, Celine Nguefeu Nkenfou

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of public health in Africa, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 66% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Merveille KemenangSchool of Health Sciences, Catholic University of Central Africa, Yaounde.
Rene EssombaSchool of Health Sciences, Catholic University of Central Africa, Yaounde.
Aubin Nanfack'Chantal Biya' International Reference Centre, Laboratory of Immunology and Microbiology, Yaounde.
Paul Fernand EndjaDominican Hospital Saint Martin de Porres, Yaounde.
Celine Nguefeu Nkenfou'Chantal Biya' International Reference Centre, Laboratory of Immunology and Microbiology, Yaounde.
Catholic University of Central Africa · CMCentre International De Reference Chantal Biya · CMSt. Martin de Porres Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the availability for nearly twenty years of an effective vaccine, hepatitis B remains one of the most frequent viral diseases throughout the world. Mother-to-child transmission is one of the primary routes of transmission in children. To assess the vaccine response in children born to HBV infected mothers. HBsAg-positive consenting mothers registered in the antenatal care (ANC) service database of

Indexed as

HBV vaccinehepatitis Bmother to child transmissionprotection level

Identifiers

PMID38204806
PMCPMC10774847
OpenAlexW4390795169

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.